CAMBRIDGE, Mass. and BIRMINGHAM, Ala., Dec. 8, 2023 /PRNewswire/ -- Alveolus Bio today announced a strategic scientific collaboration with BiomEdit, an emerging animal health biotechnology company ...
Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies "Securing Shilpa as our lead investor is a transformative step," said Gaurav ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results